Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice

This publication has 42 references indexed in Scilit:

• Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: inhibition of TNF-α and upregulation of IL-10 release
  International Journal of Immunopharmacology, 1999
• Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide
  American Journal of Kidney Diseases, 1998
• Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts
  Transplant Immunology, 1996
• MYCOPHENOLIC ACID, AN INHIBITOR OF IMP DEHYDROGENASE THAT IS ALSO AN IMMUNOSUPPRESSIVE AGENT, SUPPRESSES THE CYTOKINE-INDUCED NITRIC OXIDE PRODUCTION IN MOUSE AND RAT VASCULAR ENDOTHELIAL CELLS
  Transplantation, 1995
• Nitric oxide synthases: Roles, tolls, and controls
  Cell, 1994
• Expression of the gene for inducible nitric oxide synthase in experimental glomerulonephritis in the rat
  Clinical and Experimental Immunology, 1994
• Function and Activation of NF-kappaB in the Immune System
  Annual Review of Immunology, 1994
• Nitric oxide and renal function
  Current Opinion in Nephrology and Hypertension, 1993
• Urinary excretion of nitrite and nitrate in experimental glomerulonephritis reflects systemic immune activation and not glomerular synthesis
  Clinical and Experimental Immunology, 1992
• Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages
  Biochemical and Biophysical Research Communications, 1991